boehringer glp-1 moves Wegovy competitor into late-stage testing Boehringer Ingelheim advances triple-agonist obesity

News provided by MENU - ORDER AI Mar 03, 2026, 14:32 ET Federal Policy Signals Accelerating GLP-1 Adoption Menu-Order-AI Translates Clinical Access into Everyday Dining Decisions BOSTON, March 3, 2026 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has announced the BALANCE Model, a voluntary initiative designed to expand access to GLP-1 medications under Medicare and Medicaid through negotiated pricing and structured coverage

Supplementing with Clostridium butyricum directly addresses this deficit

Blood Cells Mol Dis 2001

Not accounting for peptide content on the COA

1 Heres a code snippet of a model writing code before and after using the Convex guidelines